A Review on the Preparation and Validation of Stability Chambers and Water Systems in Accordance with Indian Pharmacopoeia (I.P.) 2022

Validation is a critical component of pharmaceutical quality assurance, mandated by Good Manufacturing Practices (GMP) and regulatory guidelines including Indian Pharmacopoeia (IP) 2022. Stability chambers and pharmaceutsical water systems represent essential infrastructure requiring stringent validation to ensure product safety, efficacy, and regulatory compliance. This study aims to generate comprehensive validation data for pharmaceutical purified water systems and stability chambers in accordance with IP 2022, WHO Technical Report Series, and ICH Q1A(R2) guidelines. The goal is to confirm that these systems consistently operate within predefined parameters, ensuring the quality of drug products throughout their lifecycle. A phase-wise, experimental validation design was implemented, involving Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) stages. For purified water systems, validation was conducted in three phases over a year, incorporating physicochemical and microbiological testing. Stability chamber validation included 3D thermal and humidity mapping across ICH zones (I to IVB and accelerated) using calibrated Electronic Data Logging M.